undefined
EUTM file information

018577198

Orshina


October 13, 2021

Trademark Summary

The trademark application Orshina was filed by Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on March 17, 2022, and it was registered by office on June 24, 2022 without any oppositions.

The application was filed in English (German was selected as the second language).


Goods And Services

  • The mark was filed in class 1 with following description of goods:
    1. Chemicals for use in industry and science, in particular reagents for labelling of biomolecules, reagents for tagging of biomolecules
    2. Reagents for visualization or detection of biomolecules
    3. Reagents for tagging of chemical entities or chemical molecules
    4. Reagents for generation of molecular constructs, transfection reagents, reagents for gene editing
    5. Reagents for investigations in relation to tissue disorders
    6. Reagents for investigations in relation to fibrosis
    7. Reagents for investigations in relation to inflammatory disorders
    8. Diagnostic reagents, not for medical or veterinary purposes
    9. Chemical reagent mixtures in kit form, other than for medical or veterinary use
    10. Kits comprising reagents for use in scientific research, in particular kits for labelling of biomolecules
    11. Kits for tagging of biomolecules comprising reagents for tagging of biomolecules
    12. Kits for visualization or detection of biomolecules comprising reagents for visualization or detection of biomolecules
    13. Kits for generation of molecular constructs comprising reagents for generation of molecular constructs
    14. Transfection kits comprising reagents for transfection of cells
    15. Kits for gene editing comprising reagents for gene editing
    16. Kits for investigations in relation to tissue disorders comprising reagents for investigations in relation to tissue disorders
    17. Kits for investigations in relation to fibrosis comprising reagents for investigations of fibrosis
    18. Kits for investigations in relation to inflammatory disorders comprising reagents for investigations of inflammatory disorders
    19. Diagnostic kits not for medical and veterinary purposes.
  • The mark was filed in class 5 with Pharmaceuticals, in particular pharmaceuticals for treating fibrosis, pharmaceuticals for treating lung diseases, pharmaceuticals for treating inflammatory disorders, pharmaceuticals for treating scars and scar formation, pharmaceuticals for promoting tissue repair and/or tissue regeneration, pharmaceuticals for wound healing, wherein all aforementioned pharmaceuticals include small chemical molecules, peptides, proteins, nucleic acids, cellular products and gene therapy products and Diagnostic reagents, for medical and veterinary purposes..
  • The mark was filed in class 9 with following description of goods:
    1. Scientific research and laboratory apparatus
    2. Apparatus for drug discovery
    3. Apparatus for drug development.
  • The mark was filed in class 42 with following description of goods:
    1. Scientific and industrial research in particular in the biochemical, diagnostic or pharmaceutical fields
    2. Biochemical or pharmaceutical laboratory services, in particular in the field of discovery and development of drugs for treating fibrosis, lung diseases, or scars, drugs for preventing scar formation or drugs for wound healing, in the field of discovery of drugs for promoting tissue repair and/or tissue regeneration
    3. Analysis of active ingredients in the field of drugs for treating fibrosis, lung diseases, or scars, or in the field of drugs for preventing scar formation or drugs for wound healing, or in the field of drugs for promoting tissue repair and/or tissue regeneration
    4. Scientific consultancy, in particular with respect to drug discovery methodologies and systems for drug discovery and with respect to drug development methodologies and systems for drug development.
  • The mark was filed in class 44 with following description of goods:
    1. Diagnosis and treatment of fibrosis, lung diseases, or scars or scar formation
    2. Diagnosis and healing of wound
    3. Promotion of tissue repair and/or tissue regeneration for treatment of inflammatory conditions
    4. Treatment prediction and diagnostics in the field of medicine and veterinary medicine.